Matthew M. Gosling
2016
In 2016, Matthew M. Gosling earned a total compensation of $2M as Senior Vice President and General Counsel at DepoMed, a 1% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $233,670 |
|---|---|
| Option Awards | $639,450 |
| Salary | $470,833 |
| Stock Awards | $642,800 |
| Other | $8,238 |
| Total | $1,994,991 |
Gosling received $642.8K in stock awards, accounting for 32% of the total pay in 2016.
Gosling also received $233.7K in non-equity incentive plan, $639.5K in option awards, $470.8K in salary and $8.2K in other compensation.
Rankings
In 2016, Matthew M. Gosling's compensation ranked 4,895th out of 14,075 executives tracked by ExecPay. In other words, Gosling earned more than 65.2% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 4,895 out of 14,075 | 65th |
Division Manufacturing | 1,742 out of 5,486 | 68th |
Major group Chemicals And Allied Products | 546 out of 1,900 | 71st |
Industry group Drugs | 402 out of 1,543 | 74th |
Industry Pharmaceutical Preparations | 320 out of 1,173 | 73rd |
Source: SEC filing on July 14, 2017.
Gosling's colleagues
We found five more compensation records of executives who worked with Matthew M. Gosling at DepoMed in 2016.
2016
James Schoeneck
DepoMed
Chief Executive Officer
2016
R Shively
DepoMed
Former Senior Vice President and Chief Commercial Officer
2016
August Moretti
DepoMed
Chief Financial Officer
2016
Srinivas Rao
DepoMed
Chief Medical Officer
2016
Thadd Vargas
DepoMed